Mr. Macdonald has 18 years experience in the pharmaceutical industry and has held senior management positions in manufacturing, consultancy, business and corporate development, data management, and clinical operations. With INC Research he has been responsible for leading the data management, data services and ultimately global services teams, driving the implementation of new technologies and processes and the expansion of those service provisions to a global scale. In addition, Mr Macdonald led the INC Business Development team and created the Alliance Development & Management functions to establish strategic partnerships to improve the speed, efficiency, and quality of drug development. Now as the leader of the Oncology Business function Mr. Macdonald is working with new and existing customers to deliver world class projects using innovative service models that create increased value through INC Research’s Oncology expertise and Trusted Process methodology.
 

Nicholas Kenny, PhD
Executive Vice President, Oncology

Dr. Smyth has over 20 years of research and development experience in the pharmaceutical industry. He began his career working in clinical operations roles of increasing responsibility for CROs. Prior to joining INC he spent 8 years at a biopharmaceutical company specializing in the development of small molecules, biologicals and DNA aptamers for the treatment of cancer. He has held senior management positions within CRO and biopharmaceutical companies in both Europe and USA and has been solely focused on hematology and oncology drug development since 2003. Dr Smyth’s extensive experience and expertise in oncology drug development has successfully ensured the timely and efficient delivery of numerous clinical trials, often ahead of schedule. He received his PhD in Reproductive Endocrinology from the University of Edinburgh, United Kingdom and his MBA from Henley Management College, United Kingdom.